Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 3 December 2025.Powered by Capital Market - Live News

Net loss of Nectar Lifescience reported to Rs 176.01 crore in the quarter ended September 2025 as against net profit of Rs 5.60 crore during the previous quarter ended September 2024. Sales declined 12.74% to Rs 5.00 crore in the quarter ended September 2025 as against Rs 5.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.005.73 -13 OPM %-6.60-10.30 - PBDT-0.300.10 PL PBT-0.50-0.35 -43 NP-176.015.60 PL Powered by Capital Market - Live News

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Nectar Lifescience announced that the 30th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News

Net loss of Nectar Lifescience reported to Rs 63.23 crore in the quarter ended June 2025 as against net profit of Rs 2.97 crore during the previous quarter ended June 2024. Sales declined 21.79% to Rs 280.67 crore in the quarter ended June 2025 as against Rs 358.85 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales280.67358.85 -22 OPM %-22.0511.09 - PBDT-80.2420.38 PL PBT-96.754.92 PL NP-63.232.97 PL Powered by Capital Market - Live News